Skip to main content
GutCited

베르베린 그림

35 동료 심사 연구의 그림

전체 생강 아연 이눌린 커큐민 락타아제 베르베린 차전자피 비피도박테리움 롱검 비피도박테리움 락티스 비피도박테리움 비피덤 사카로마이세스 보울라디 락토바실루스 가세리 락토바실루스 플란타룸 락토바실루스 애시도필루스 부티레이트(나트륨/칼슘 부티레이트) 페퍼민트 오일 바실루스 코아굴란스 췌장효소(판크렐리파아제) 알로에 베라(내엽 젤) 알파-갈락토시다아제 소 초유 오메가-3 지방산(EPA/DHA) 비타민 A 비타민 D 프럭토올리고당(FOS) 갈락토올리고당(GOS) L-글루타민 중쇄중성지방(MCT 오일) N-아세틸시스테인(NAC)
All Types Chart Diagram Photograph Flowchart Forest Plot Micrograph Other
Figure 11
Figure 11 Chart

Supplementary experimental data (panel 11) from the berberine autoimmune hepatitis study, providing additional evidence of gut microbiota modulation and hepatoprotective effects in the concanavalin A mouse model.

Berberine alleviates concanavalin A-induced autoimmune hepatitis in mice by modulating the gut …

BBR
Figure 17 Diagram

Graphical summary of berberine's mechanism of action in alleviating concanavalin A-induced autoimmune hepatitis in mice, highlighting its role in modulating the gut microbiota and restoring intestinal barrier integrity.

Berberine alleviates concanavalin A-induced autoimmune hepatitis in mice by modulating the gut …

Figure 18
Figure 18 Chart

Extended analysis from the berberine autoimmune hepatitis study, examining molecular pathways or additional biomarkers related to gut-liver axis communication and intestinal barrier function.

Berberine alleviates concanavalin A-induced autoimmune hepatitis in mice by modulating the gut …

Figure 19
Figure 19 Chart

Extended analysis from the berberine autoimmune hepatitis study, examining molecular pathways or additional biomarkers related to gut-liver axis communication and intestinal barrier function.

Berberine alleviates concanavalin A-induced autoimmune hepatitis in mice by modulating the gut …

Figure 20
Figure 20 Chart

Extended analysis from the berberine autoimmune hepatitis study, examining molecular pathways or additional biomarkers related to gut-liver axis communication and intestinal barrier function.

Berberine alleviates concanavalin A-induced autoimmune hepatitis in mice by modulating the gut …

Figure 29
Figure 29 Chart

Gut microbiota sequencing or metabolomic data from the berberine-treated autoimmune hepatitis model, characterizing microbial community shifts and their potential functional implications.

Berberine alleviates concanavalin A-induced autoimmune hepatitis in mice by modulating the gut …

Figure 30
Figure 30 Chart

Gut microbiota sequencing or metabolomic data from the berberine-treated autoimmune hepatitis model, characterizing microbial community shifts and their potential functional implications.

Berberine alleviates concanavalin A-induced autoimmune hepatitis in mice by modulating the gut …

Figure 35
Figure 35 Chart

Gut microbiota sequencing or metabolomic data from the berberine-treated autoimmune hepatitis model, characterizing microbial community shifts and their potential functional implications.

Berberine alleviates concanavalin A-induced autoimmune hepatitis in mice by modulating the gut …

Figure 40
Figure 40 Chart

Additional supplementary data from the comprehensive berberine autoimmune hepatitis study, further supporting the connection between gut microbiota modulation and liver inflammation resolution.

Berberine alleviates concanavalin A-induced autoimmune hepatitis in mice by modulating the gut …

Figure 1
Figure 1

Natural Bioactive Compounds in the Management of Type 2 Diabetes and Metabolic …

Figure 2. NBCs with potential therapeutic roles in T2D and MASLD.
Figure 3

Figure 2. NBCs with potential therapeutic roles in T2D and MASLD.

Natural Bioactive Compounds in the Management of Type 2 Diabetes and Metabolic …

2페이지 중 2페이지